Achieving HCV Elimination in the United States: Progress and Next Steps

In this online educational program, expert faculty explore what will be needed to achieve HCV elimination in the United States. Choose from 6 short foundational videos, 3 ClinicalThought commentaries, and a module with accompanying slideset that details answers to commonly asked questions on the management of key at-risk populations.
Norah Terrault, MD, MPH
Program Director
Frederick L. Altice, MD
Jordan J. Feld, MD, MPH
Alain H. Litwin, MD
Natasha Martin, DPhil
person default
Brianna L. Norton, DO
Christian Ramers Headshot
Christian B. Ramers, MD, MPH
Lara Strick, MD, MS
Norah Terrault, MD, MPH

Video Modules

Watch and listen as Frederick L. Altice, MD, and Norah Terrault, MD, MPH, discuss current and emerging trends in the epidemiology of HCV infection in the United States with a focus on what these trends mean for strategies aimed at achieving HCV elimination.

Norah Terrault, MD, MPH
Program Director
Frederick L. Altice, MD Norah Terrault, MD, MPH
Physicians: maximum of 0.5 AMA PRA Category 1 Credits Registered Nurses: 0.4 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: October 18, 2017 Expiration: October 17, 2018

Watch and listen as Jordan J. Feld, MD, MPH, and Natasha Martin, DPhil, discuss what makes achieving HCV elimination feasible: targeting at-risk populations, delivering multiple interventions, and personalizing interventions to optimize outcomes by risk group.

Norah Terrault, MD, MPH
Program Director
Jordan J. Feld, MD, MPH Natasha Martin, DPhil
Physicians: maximum of 0.5 AMA PRA Category 1 Credits Registered Nurses: 0.4 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: October 24, 2017 Expiration: October 23, 2018

Watch and listen as Jordan J. Feld, MD, MPH, and Natasha Martin, DPhil, discuss how dramatic changes in the HCV treatment landscape have enabled high cure rates to be safely achieved across a wide range of patient populations, including those previously excluded from HCV therapy because of previous or ongoing injection drug use. Expert faculty will also discuss how improved therapies have led to the concept of HCV treatment-as-prevention among high-risk populations as a critical strategy to reduce HCV incidence and prevalence in the United States.

Norah Terrault, MD, MPH
Program Director
Jordan J. Feld, MD, MPH Natasha Martin, DPhil
Physicians: maximum of 0.5 AMA PRA Category 1 Credits Registered Nurses: 0.4 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: October 18, 2017 Expiration: October 17, 2018

Watch and listen as Frederick L. Altice, MD, and Natasha Martin, DPhil, discuss the current structural, geographic, and patient-specific barriers to HCV elimination in the United States.

Norah Terrault, MD, MPH
Program Director
Frederick L. Altice, MD Natasha Martin, DPhil
Physicians: maximum of 0.5 AMA PRA Category 1 Credits Registered Nurses: 0.4 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: October 27, 2017 Expiration: October 26, 2018

Watch and listen as Alain H. Litwin, MD, and Brianna L. Norton, DO, discuss the roles of primary care physicians in screening, diagnosing, treating, and referring patients infected with HCV.

Norah Terrault, MD, MPH
Program Director
Alain H. Litwin, MD person default Brianna L. Norton, DO
Physicians: maximum of 0.5 AMA PRA Category 1 Credits Registered Nurses: 0.4 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: October 27, 2017 Expiration: October 26, 2018

Watch and listen as Jordan J. Feld, MD, MPH, and Norah Terrault, MD, MPH, discuss the evolving roles of hepatologists, gastroenterologists, and infectious disease clinicians in the current HCV treatment landscape and review important strategies that these specialists can take in moving toward the goals of HCV elimination in the United States.

Norah Terrault, MD, MPH
Program Director
Jordan J. Feld, MD, MPH Norah Terrault, MD, MPH
Physicians: maximum of 0.5 AMA PRA Category 1 Credits Registered Nurses: 0.4 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: October 30, 2017 Expiration: October 29, 2018

ClinicalThought

With long-term health and wellness as a framing principle, curing HCV is not the finish line but rather a starting point for a conversation about maintaining wellness, preventing progression of liver disease, addressing harmful drug and alcohol habits, and, of importance, preventing HCV reinfection.

Christian Ramers Headshot Christian B. Ramers, MD, MPH Released: November 30, 2017

Implementation of prevention services targeting incarcerated patients is possible. Let me tell you why.

Lara Strick, MD, MS Released: December 12, 2017

Eliminating HCV infection among persons who inject drugs is a daunting task whether tackling it from a patient care perspective, through practice transformation, or by influencing policies that improve access to treatment. Nonetheless, there are practical steps that can be taken by clinicians to improve the HCV continuum of care for this challenging population. Here’s my take on some of those steps.

Frederick L. Altice, MD Released: January 19, 2018

FAQ Module

In this downloadable slideset, Frederick L. Altice, MD, Christian Ramers MD, MPH, and Lara Strick, MD, respond to common questions on the elimination of HCV infection in key high-risk communities.

Released: October 18, 2017

In this CME/CE-certified module, experts provide answers to common questions about best practices in the management of incarcerated individuals, men who have sex with men, and persons who inject drugs essential to the elimination of HCV as a public health threat.

Norah Terrault, MD, MPH
Program Director
Frederick L. Altice, MD Christian Ramers Headshot Christian B. Ramers, MD, MPH Lara Strick, MD, MS
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: October 18, 2017 Expiration: October 17, 2018

Downloadable Slidesets

In this downloadable slideset, Frederick L. Altice, MD, and Norah Terrault, MD, MPH, review current and emerging trends in the epidemiology of HCV infection in the United States with a focus on what these trends mean for strategies aimed at achieving HCV elimination.

Released: October 18, 2017

In this downloadable slideset, Jordan J. Feld, MD, MPH, and Natasha Martin, DPhil, review modeling data indicating critical steps needed to achieve HCV elimination targets in the United States: reaching at-risk populations, delivering multiple interventions, and personalizing interventions to optimize outcomes by risk group.

Released: October 24, 2017

In this downloadable slideset, Jordan J. Feld, MD, MPH, and Natasha Martin, DPhil, review how dramatic changes in the HCV treatment landscape have enabled high cure rates to be safely achieved across a wide range of patient populations, including those previously excluded from HCV therapy because of previous or ongoing injection drug use.

Released: October 18, 2017

In this downloadable slideset, Frederick L. Altice, MD, and Natasha Martin, DPhil, review the current structural, geographic, and patient-specific barriers to HCV elimination in the United States.

Released: October 27, 2017

In this downloadable slideset, Alain H. Litwin, MD, and Brianna L. Norton, DO, review the essential roles of primary care physicians in screening, diagnosing, treating, and referring patients infected with HCV to achieve key HCV elimination goals in the United States.

Released: October 27, 2017

In this downloadable slideset, Jordan J. Feld, MD, MPH, and Norah Terrault, MD, MPH, discuss the evolving roles of hepatologists, gastroenterologists, and infectious disease clinicians in the current HCV treatment landscape and review important strategies that these specialists can take in moving toward the goals of HCV elimination in the United States.

Released: October 30, 2017

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?